Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo
Photodermatology, Photoimmunology & Photomedicine · 2024-01 · 40 (1)
DOI: 10.1111/phpp.12929 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, online erschienen am 20.11.2023. Verfasst von Manal Fawzy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Ultraviolet Therapy, Vitiligo. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Narrowband ultraviolet B (NB‐UVB) phototherapy is the cornerstone of vitiligo treatment. Its combination with other treatments usually yields a better response. Latanoprost, a prostaglandin F2α analog, and autologous platelet‐rich plasma (PRP) have been reported to be effective for vitiligo.
Aim
To evaluate the efficacy of NB‐UVB combined with intralesional latanoprost or PRP for stable nonsegmental vitiligo (NSV).
Methods
Sixty patients with stable NSV were recruited and randomly allocated to two equal groups. NB‐UVB phototherapy was administered twice a week for all patients. Additionally, group A received intralesional latanoprost injections once weekly, while group B received intralesional autologous PRP injections every 2 weeks.
Results
At 24 weeks, excellent repigmentation response was observed in 26.7% and 13.3% of patients in the latanoprost/NB‐UVB and PRP/NB‐UVB groups, respectively, with no significant difference in degrees of repigmentation between the two groups. However, the Vitiligo Extent Score for a Target Area (VESTA) score was significantly higher in the latanoprost/NB‐UVB group ( p = .032). Moreover, lesions located on nonacral skin responded significantly better than those on acral skin. Only erythema was significantly higher in the PRP/NB‐UVB group, while the recurrence of depigmentation was significantly higher in the latanoprost/NB‐UVB group.
Conclusions
Both latanoprost and PRP have the potential to be effective add‐on therapies to NB‐UVB phototherapy for stable NSV, with latanoprost resulting in a greater repigmentation response and PRP producing a more stable response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
ORCID-Profile: Manal Fawzy
Zitieren
APA
Fawzy, M., Al-Mokadem, S., Alshereef, M., & Elkholy, B. (2024). Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo. Photodermatology, Photoimmunology & Photomedicine, 40(1). https://doi.org/10.1111/phpp.12929
Vancouver
Fawzy M, Al-Mokadem S, Alshereef M, Elkholy B. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo. Photodermatology, Photoimmunology & Photomedicine. 2024;40(1). doi:10.1111/phpp.12929
BibTeX
@article{Fawzy2024,
author = {Fawzy, Manal and Al-Mokadem, Sahar and Alshereef, Mabrokah and Elkholy, Basma},
title = {Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2024},
volume = {40},
number = {1},
doi = {10.1111/phpp.12929}
}
EUVIMED